¼¼°èÀÇ ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Cardiac Arrhythmia Monitoring Devices
»óǰÄÚµå : 1650985
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀå, 2030³â±îÁö 127¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â 93¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ Àåºñ ¼¼°è ½ÃÀåÀº 2024-2030³â µ¿¾È ¿¬Æò±Õ 5.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 127¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¾ÈÁ¤½Ã ECG ±â±â´Â CAGR 4.5%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 49¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ECG ½ºÆ®·¹½º Å×½ºÆ® Àåºñ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 25¾ï ´Þ·¯, Áß±¹Àº CAGR 5.0%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â 25¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 5.0%ÀÇ CAGR·Î 2030³â±îÁö 20¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 4.9% ¹× 4.4%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â¶õ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â´Â Çö´ë ½ÉÀåÇп¡¼­ Áß¿äÇÑ ±â¼ú·Î µîÀåÇßÀ¸¸ç, ƯÈ÷ ½ÉÀå ¸®µëÀÇ ºÒ±ÔÄ¢¼ºÀ» °¨ÁöÇÏ°í ±â·ÏÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ½É¹æ¼¼µ¿, ¼­¸Æ, ºó¸Æ, ºó¸Æ ¹× ±âŸ ½ÉÀå ¸®µë Àå¾Ö¿Í °°ÀÌ ³úÁ¹Áß, ½ÉºÎÀü µî ½É°¢ÇÑ °Ç°­ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ÁúȯÀ» Áø´ÜÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ÉÀå ºÎÁ¤¸ÆÀº ½ÉÀåÀÇ Àü±â ÀÚ±ØÀÌ Á¦ ±â´ÉÀ» ÇÏÁö ¸øÇÏ°í ½ÉÀå ¹Úµ¿ÀÌ ³Ê¹« ºü¸£°Å³ª ´À¸®°Å³ª ºÒ±ÔÄ¢ÇÏ°Ô ¶Ù´Â °ÍÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óŸ¦ Á¤È®ÇÏ°Ô Áø´ÜÇϱâ À§ÇØ È¦ÅÍ ¸ð´ÏÅÍ, À̺¥Æ® ·¹ÄÚ´õ, À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ¿Í °°Àº ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â°¡ ¹èÄ¡µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ÀÏÁ¤ ±â°£ µ¿¾È ½ÉÀå Ȱµ¿À» ±â·ÏÇÏ¿© Àǻ簡 ºÎÁ¤¸ÆÀÇ ÆÐÅÏÀ» ºÐ¼®ÇÏ°í ±×¿¡ µû¶ó Ä¡·á °èȹÀ» ¼¼¿ï ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ »ç¿ëÀº ½ÉÀå Àü¹®Àǰ¡ ½ÉÀå »óÅÂ, ƯÈ÷ ÀϹÝÀûÀÎ °Ë»ç·Î´Â ¾Ë ¼ö ¾ø´Â ½ÉÀå »óŸ¦ ¹ß°ßÇÏ´Â ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù.

ÀÌ·¯ÇÑ ÀåºñÀÇ Ãֽбâ¼ú ¹ßÀüÀº ¸ð´ÏÅ͸µÀ» ¾î¶»°Ô °³¼±ÇÒ ¼ö ÀÖÀ»±î?

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ºÐ¾ß¿¡¼­´Â ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Á¤È®¼º, ÆíÀǼº ¹× È¿À²¼ºÀ» Å©°Ô Çâ»ó½ÃŰ´Â Áß¿äÇÑ ±â¼ú ¹ßÀüÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÇöÀç ¸¹Àº ¸ð´ÏÅ͸µ ±â±â°¡ ¹«¼± ¿¬°á ±â´ÉÀ» °®Ãß°í ÀÖ¾î ¸ð¹ÙÀÏ ¹× Ŭ¶ó¿ìµå Ç÷§ÆûÀ» ÅëÇØ ÀÇ·á Àü¹®°¡¿¡°Ô ½Ç½Ã°£ µ¥ÀÌÅ͸¦ ¿øÈ°ÇÏ°Ô Àü¼ÛÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀº ȯÀÚ°¡ ÀÚÁÖ º´¿øÀ» ¹æ¹®ÇÏÁö ¾Ê¾Æµµ µÇ°í, ¿ø°ÝÁö¿¡¼­µµ µ¥ÀÌÅ͸¦ ¾ÈÁ¤ÀûÀ¸·Î Àü¼ÛÇÒ ¼ö ÀÖ¾î º¸´Ù Àû½Ã¿¡ Áø´Ü°ú °³ÀÔÀ» ÇÒ ¼ö ÀÖ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ±â±âÀÇ ¼ÒÇüÈ­´Â ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í, ƯÈ÷ À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ´Â ´«¿¡ ¶çÁö ¾Ê°Ô ÇÇÇÏ¿¡ À̽ÄÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀÎ À¯Áöº¸¼ö ¾øÀ̵µ ¼ö³â°£ ÀÛµ¿ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡¿Í °°Àº ¿þ¾î·¯ºí ÀåÄ¡µµ µîÀåÇÏ¿© ´«¿¡ ¶çÁö ¾Ê´Â ¹æ½ÄÀ¸·Î Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿þ¾î·¯ºí ±â±âÀÇ ´ëºÎºÐÀº ½ÉÀåÀÇ ºñÁ¤»óÀûÀÎ ¸®µëÀ» °¨ÁöÇÏ°í »ç¿ëÀÚ¿¡°Ô °æ°íÇÒ ¼ö ÀÖ´Â °í±Þ ¾Ë°í¸®ÁòÀ» °®Ãß°í ÀÖ¾î °³ÀÎ °Ç°­ ¸ð´ÏÅ͸µÀÌ ±× ¾î´À ¶§º¸´Ù Ä£¼÷ÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­ µ¥ÀÌÅÍ¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí Á¶±â °³ÀÔÀ» ¿äûÇÒ ¼ö ÀÖ´Â »çÀü ¿¹¹æÀû ½ÉÀå Ä¡·á·ÎÀÇ Å« ÀüȯÀ» ÀǹÌÇÕ´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÀÓ»ó µ¿Çâ°ú ¼ÒºñÀÚ µ¿ÇâÀº?

½ÉÇ÷°üÁúȯ À¯º´·üÀÇ Áõ°¡, ¼¼°è Àα¸ÀÇ °í·ÉÈ­, ½ÉÀå °Ç°­¿¡ ´ëÇÑ ÀϹÝÀÎÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ºñ¸¸, ´ç´¢º´ µî »ýȰ½À°üº´ÀÇ Áõ°¡´Â ºÎÁ¤¸Æ ȯÀÚÀÇ Áõ°¡¿Í ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ½À´Ï´Ù. ³ëÀεéÀº ½ÉÀå Áúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ Àå±âÀûÀÌ°í ºñħ½ÀÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ÒºñÀÚ ÁÖµµÇü ÀÇ·á ¼­ºñ½º·ÎÀÇ ÀüȯÀÌ µÎµå·¯Áö°í °³ÀÎÀÌ ÀÚ½ÅÀÇ °Ç°­À» °ü¸®ÇÏ°Ô µÊ¿¡ µû¶ó ÈÞ´ë¿ë ¹× »ç¿ëÀÚ Ä£È­ÀûÀÎ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú °¡»ó Áø·á°¡ °¡´ÉÇÏ¿© º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙ¿©ÁÖ´Â ¿ø°ÝÀÇ·á°¡ ³Î¸® äÅõǰí ÀÖ´Â °Íµµ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿Í ÇÔ²² ¸¹Àº ±¹°¡¿¡¼­ ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀ» º¸ÀåÇÏ´Â º¸Çè ȯ±Þ Á¤Ã¥ÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, °æÁ¦Àû ºÎ´ã ¾øÀÌ ÀÌ·¯ÇÑ ±â±â¸¦ »ç¿ëÇϴ ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â »ê¾÷ ȯ°æÀº ÀÇ·á±â±â ¾÷°è°¡ º¸´Ù ½º¸¶Æ®Çϰí Á÷°üÀûÀÎ ½ÉÀå ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» °³¹ßÇÔÀ¸·Î½á ÀÓ»óÀû ¿ä±¸¿Í ¼ÒºñÀÚÀÇ ±â´ë¿¡ ºÎÀÀÇϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

½ÉÀå ºÎÁ¤¸Æ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ÀüÅëÀûÀÎ ÇコÄÉ¾î ÆÐ·¯´ÙÀÓÀ» ³Ñ¾î¼­´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ¿þ¾î·¯ºí ¹× À̽ÄÇü ÀåÄ¡ÀÇ ±Þ¼ÓÇÑ ±â¼ú Çõ½ÅÀ¸·Î ¼ÒÇüÈ­, Á¤¹ÐÈ­, »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ¾î ȯÀÚ¿Í ÀÓ»óÀÇ¿¡°Ô ¸Å·ÂÀûÀÎ Á¦Ç°À¸·Î °Åµì³ª°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡¼­ÀÇ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ µîÀåÀº ÀÌ·¯ÇÑ Ãß¼¼¸¦ ´õ¿í ÁõÆø½ÃÄÑ ºÎÁ¤¸Æ »ç°ÇÀ» »çÀü¿¡ ½Äº°ÇÒ ¼ö ÀÖ´Â ¿¹Ãø ºÐ¼®À» °¡´ÉÇÏ°Ô ÇÏ¿© ¿¹¹æÀÇÇп¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÉÀå °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í ½Ç½Ã°£ Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ¿ø°ÝÀÇ·á »ýŰèÀÇ È®ÀåÀÔ´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ ÀÇ·á Á¢±Ù¼º¿¡ ´ëÇÑ Çʿ伺À¸·Î ÀÎÇØ ´õ¿í º¸ÆíÈ­µÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è °í·ÉÈ­µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ³ëÀεéÀº ½ÉÀå Áúȯ¿¡ °É¸®±â ½¬¿ö ÀϰüµÇ°í Àå±âÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ºÏ¹Ì¿Í À¯·´°ú °°Àº Áö¿ª¿¡¼­´Â ÷´Ü ¸ð´ÏÅ͸µ ±â±âÀÇ ½ÂÀÎ ÀýÂ÷°¡ °£¼ÒÈ­µÇ¾î ½ÃÀå¿¡¼­ÀÇ »ç¿ëÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, Á¶±â ¹ß°ß°ú Á¶±â °³ÀÔÀ» ÅëÇØ ÀÔ¿øÀ» ¿¹¹æÇÔÀ¸·Î½á ½ÉÀå Ä¡·áÀÇ ÃÑ ºñ¿ëÀ» Àý°¨ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÇコÄÉ¾î ¾÷°èÀÇ °¡Ä¡ ±â¹Ý Ä¡·á·ÎÀÇ ÀüȯÀÌ ÀÌ·¯ÇÑ ±â±âÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¾ÈÁ¤½Ã ½ÉÀüµµ ÀåÄ¡, ½ÉÀüµµ ºÎÇÏ Å×½ºÆ® ÀåÄ¡, ȦÅÍ ¸ð´ÏÅÍ, ±âŸ Á¦Ç° À¯Çü), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü ¼¾ÅÍ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÁÖ¸ñ 44°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Arrhythmia Monitoring Devices Market to Reach US$12.7 Billion by 2030

The global market for Cardiac Arrhythmia Monitoring Devices estimated at US$9.3 Billion in the year 2024, is expected to reach US$12.7 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Resting ECG Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the ECG Stress Test Devices segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 5.0% CAGR

The Cardiac Arrhythmia Monitoring Devices market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Cardiac Arrhythmia Monitoring Devices Market - Key Trends and Drivers Summarized

What Are Cardiac Arrhythmia Monitoring Devices and Why Are They Important?

Cardiac arrhythmia monitoring devices have emerged as a crucial technology in modern cardiology, specifically designed to detect and record irregularities in the heart's rhythm. These devices play an essential role in diagnosing conditions like atrial fibrillation, bradycardia, tachycardia, and other heart rhythm disorders that may lead to severe health complications such as stroke or heart failure. Typically, cardiac arrhythmias occur when the electrical impulses in the heart do not work as they should, leading to too fast, too slow, or irregular heartbeats. To diagnose these conditions accurately, arrhythmia monitoring devices such as Holter monitors, event recorders, and implantable loop recorders are deployed. These devices record cardiac activity over a period, often in real-time, allowing doctors to analyze patterns of irregular heartbeats and tailor treatment plans accordingly. The use of these devices has revolutionized how cardiologists detect heart conditions, particularly those that may not be obvious during a routine medical examination.

How Do the Latest Technological Advancements in These Devices Improve Monitoring?

The field of cardiac arrhythmia monitoring has witnessed significant technological advancements that have considerably improved the accuracy, convenience, and effectiveness of these devices. For instance, many monitoring devices now feature wireless connectivity, enabling seamless real-time data transmission to healthcare professionals through mobile or cloud platforms. This technology eliminates the need for patients to visit the clinic frequently, ensuring that data is transmitted from remote locations, allowing for more timely diagnosis and intervention. Additionally, the miniaturization of these devices has enhanced patient comfort, particularly with implantable loop recorders that can be discreetly placed under the skin and function for several years without the need for regular maintenance. Wearable devices like smartwatches have also entered the scene, providing continuous monitoring in an unobtrusive manner. Many of these wearable devices are equipped with sophisticated algorithms capable of detecting and alerting users of abnormal heart rhythms, making personal health monitoring more accessible than ever before. These developments mark a significant shift towards proactive cardiac care, where patients can actively engage with their health data and seek early interventions.

What Are the Key Clinical and Consumer Trends in This Market?

The demand for cardiac arrhythmia monitoring devices has soared due to a combination of rising cardiovascular disease prevalence, an aging global population, and increased public awareness about heart health. The growing incidence of lifestyle-related conditions like hypertension, obesity, and diabetes is closely linked to the rise in heart arrhythmia cases. With the elderly being more susceptible to cardiac conditions, the need for long-term, non-invasive monitoring solutions has escalated. Furthermore, there is a noticeable shift towards consumer-driven healthcare, where individuals are increasingly taking control of their health, leading to a higher demand for portable and user-friendly devices. The market is also influenced by the broader adoption of telemedicine, which allows for continuous monitoring and virtual consultations, reducing the need for hospital visits. Alongside these trends, reimbursement policies in many countries have expanded to cover remote monitoring technologies, which is encouraging more patients to utilize these devices without worrying about the financial burden. This evolving landscape highlights how the medical device industry is responding to both clinical needs and consumer expectations by creating smarter, more intuitive cardiac monitoring solutions.

What Are the Key Drivers Behind the Growth of the Cardiac Arrhythmia Monitoring Devices Market?

The growth in the cardiac arrhythmia monitoring devices market is driven by several factors that go beyond the traditional healthcare paradigm. One of the primary drivers is the rapid technological innovation in wearable and implantable devices, which are becoming smaller, more accurate, and easier to use, appealing to both patients and clinicians. The rise of artificial intelligence (AI) and machine learning in healthcare has further amplified this trend, enabling predictive analytics that can identify arrhythmic events before they occur, thus aiding in preventative care. Additionally, increased consumer awareness regarding heart health, coupled with a growing preference for real-time, continuous health monitoring, has significantly fueled demand. Another crucial factor is the expansion of the telehealth ecosystem, where remote patient monitoring has become more mainstream driven by the need for healthcare access in underserved areas. The global aging population also plays a pivotal role, as older adults are more prone to heart conditions and require consistent, long-term monitoring. Moreover, favorable regulatory changes, particularly in regions like North America and Europe, have streamlined the approval process for advanced monitoring devices, speeding up their availability in the market. Finally, the healthcare industry's shift towards value-based care is promoting the use of these devices, as they can reduce the overall cost of cardiac care by preventing hospital admissions through early detection and intervention.

SCOPE OF STUDY:

The report analyzes the Cardiac Arrhythmia Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Resting ECG Devices, ECG Stress Test Devices, Holter Monitors, Other Product Types); End-Use (Hospitals & Clinics, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â